Home › Trial NCT03411161
S 81694 Plus Paclitaxel in Metastatic Breast Cancer
- Trial IDNCT03411161
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorInstitut de Recherches Internationales Servier
- Enrollment22
- Start date2018-01-04
- ConditionsMetastatic Breast Cancer · Metastatic Triple Negative Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.